Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 200

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis

Khunti, Kamlesh, Ceriello, Antonio, Cos, Xavier, De Block, Christophe · 2018 · Diabetes Research and Clinical Practice

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2017.12.004

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 55

  1. Colhoun, 2004, Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial, Lancet (London, England), 364, 685, 10.1016/S0140-6736(04)16895-5 · DOI · Paper page
  2. Stone, 2010, Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries, Diabetes Res Clin Pract, 87, 252, 10.1016/j.diabres.2009.10.020 · DOI
  3. Soidán, 2010, Clinical practice guidelines in type 2 diabetes mellitus: similarities and discrepancies, Med Clin, 135
  4. Nathan, 2006, Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy, A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes, 29, 1963
  5. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 2012;35(6):1364–79. · DOI · Paper page
  6. American Diabetes Association, 2017, Standards of medical care in diabetes—2017: summary of revisions, Diabetes Care, 40, S4, 10.2337/dc17-S003 · DOI · Paper page
  7. Ryden, 2013, Eur Heart J, 34, 3035, 10.1093/eurheartj/eht108 · DOI · Paper page
  8. Stone, 2013, Quality of care of people with type 2 diabetes in eight European Countries: findings from the guideline adherence to enhance care (GUIDANCE) study, Diabetes Care, 36, 2628, 10.2337/dc12-1759 · DOI · Paper page
  9. Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ (Clin Res ed.), 339, b2535, 10.1136/bmj.b2535 · DOI · Paper page
  10. Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
  11. Andrade JF, Silva V, Melnik T. Mulberry therapy for type 2 diabetes mellitus. Cochrane Database Syst Rev 2015(5). · DOI
  12. Ferket, 2010, Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check?, Arch Intern Med, 170, 27, 10.1001/archinternmed.2009.434 · DOI · Paper page
  13. Ferket BS, Grootenboer N, Colkesen EB, Visser JJ, van Sambeek MRHM, Spronk S, et al. Systematic review of guidelines on abdominal aortic aneurysm screening. J Vasc Surg 55(5):1296–1304.e4. · DOI
  14. DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  15. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ (Clin Res ed.), 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  16. Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ (Clin Res ed.), 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
  17. Stark, 2011, Medical care of type 2 diabetes in German Disease Management Programmes: a population-based evaluation, Diabetes/Metab Res Rev, 27, 383, 10.1002/dmrr.1186 · DOI
  18. Davidson, 2008, A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients, Clin Ther, 30, 287, 10.1016/j.clinthera.2008.02.007 · DOI
  19. Bala, 2013, Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study, Pol Arch Med Wewn, 123, 573, 10.20452/pamw.1964 · doi:10.20452/pamw.1964
  20. Bala, 2011, Cardiovascular risk factors control in Polish patients with type 2 diabetes within the first two years of diagnosis: results of the ARETAEUS1 study, Kardiologia polska, 69, 1249
  21. Bala, 2011, Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study, Pol Arch Med Wewn, 121, 7
  22. Miñambres, 2016, Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain, BMC Endocr Disord, 16, 10, 10.1186/s12902-016-0090-1 · DOI
  23. Vaccaro, 2008, The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy, Atherosclerosis, 198, 396, 10.1016/j.atherosclerosis.2007.10.026 · DOI
  24. Leśniak, 2015, Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study, Cardiol J, 22, 150, 10.5603/CJ.a2014.0067 · DOI
  25. Bala, 2014, Management and treatment goals in Polish patients with type 2 diabetes of more than ten years' duration – results of ARETAEUS2-Grupa Study, Endokrynologia Polska, 65, 158
  26. Al-Taweel, 2013, Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait, Int J Clin Pharm, 35, 244, 10.1007/s11096-012-9738-8 · DOI
  27. Issam Diab, 2013, Adherence to clinical guidelines in management of diabetes and prevention of cardiovascular disease in Qatar, Int J Clin Pharm, 35, 101, 10.1007/s11096-012-9714-3 · DOI
  28. Mafauzy, 2011, The status of diabetes control in Malaysia: results of Diabcare 2008, Med J Malaysia, 66, 175
  29. Latif, 2011, Evaluation of management, control, complications and psychosocial aspects of diabetics in Bangladesh: DiabCare Bangladesh 2008, Bangladesh Med Res Counc Bull, 37, 11, 10.3329/bmrcb.v37i1.7793 · DOI
  30. American Diabetes Association, 2005, Standards of medical care in diabetes–2006, Diabetes Care, 29, s4, 10.2337/diacare.28.suppl_1.S4 · DOI · Paper page
  31. Rao, 2015, Comparison of the adherence to the american diabetes association guidelines of diabetes care in primary care and subspecialty clinics, J Diabet Metab Disord, 14, 35, 10.1186/s40200-015-0158-x · DOI
  32. Al Harbi, 2015, Adherence to the American Diabetes Association standards of care among patients with type 2 diabetes in primary care in Saudi Arabia, Saudi Med J, 36, 221, 10.15537/smj.2015.2.9603 · DOI
  33. Ali, 2013, Evaluation of factors associated with inadequate glycemic control and some other health care indicators among patients with type 2 diabetes in Ramallah, Palestine, Res J Pharmaceut, Biol Chem Sci, 4, 445
  34. Meyer, 2010, Comanagement of elderly patients with type 2 diabetes: better adherence to ADA guidelines?, Osteopathic Family Phys, 2, 160, 10.1016/j.osfp.2010.04.001 · doi:10.1016/j.osfp.2010.04.001
  35. Rodríguez, 2011, Blood glucose control and quality of health care in non-insulin-treated patients with Type 2 diabetes in Spain: a retrospective and cross-sectional observational study, Diabetic Med: J Brit Diabet Assoc, 28, 731, 10.1111/j.1464-5491.2011.03258.x · DOI
  36. UK Prospective Diabetes Study Group, 1998, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39, BMJ (Clin Res ed.), 317, 713, 10.1136/bmj.317.7160.713 · DOI · Paper page
  37. Wild, 2004, Global prevalence of diabetes, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047 · DOI · Paper page
  38. Oellgaard, 2017, Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits, Kidney Int, 91, 982, 10.1016/j.kint.2016.11.023 · DOI
  39. O'Connor, 1997, Differences between diabetic patients who do and do not respond to a diabetes care intervention: a qualitative analysis, Fam Med, 29, 424
  40. Grant, 2011, Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines, Diabetes Educ, 37, 78, 10.1177/0145721710388427 · DOI
  41. Farquhar, 2002, Clinicians' attitudes to clinical practice guidelines: a systematic review, Med J Australia, 177, 502, 10.5694/j.1326-5377.2002.tb04920.x · DOI · Paper page
  42. Cranney, 2001, Why do GPs not implement evidence-based guidelines? A descriptive study, Fam Pract, 18, 359, 10.1093/fampra/18.4.359 · DOI · Paper page
  43. Carlsen, 2007, Thou shalt versus thou shalt not: a meta-synthesis of GPs' attitudes to clinical practice guidelines, Brit J Gen Pract: J R Coll Gen Practition, 57, 971, 10.3399/096016407782604820 · DOI · Paper page
  44. Cahn, 2015, Clinical assessment of individualized glycemic goals in patients with type 2 diabetes: formulation of an algorithm based on a survey among leading worldwide diabetologists, Diabetes Care, 38, 2293, 10.2337/dc15-0187 · DOI
  45. Larme, 2001, Evidence-based guidelines meet the real world, Case Diabet Care, 24, 1728, 10.2337/diacare.24.10.1728 · DOI
  46. Hermans, 2013, Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial, Diabetes Care, 36, 3388, 10.2337/dc12-1853 · DOI
  47. Prior, 2008, The effectiveness of clinical guideline implementation strategies–a synthesis of systematic review findings, J Eval Clin Pract, 14, 888, 10.1111/j.1365-2753.2008.01014.x · DOI · Paper page
  48. Comin E, Catalan-Ramos A, Iglesias-Rodal M, Grau M, Del Val JL, Consola A, et al. Impact of implementing electronic clinical practice guidelines for the diagnosis, control and treatment of cardiovascular risk factors: a pre-post controlled study. Atencion primaria 2017. · DOI
  49. Simmons, 2017, Diabetologia, 60, 1016, 10.1007/s00125-017-4230-6 · DOI
  50. Ament SMC, de Groot JJA, Maessen JMC, Dirksen CD, van der Weijden T, Kleijnen J. Sustainability of professionals’ adherence to clinical practice guidelines in medical care: a systematic review. BMJ Open 2015;5(12). · DOI · Paper page
  51. Ji, 2013, Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables, BMC Publ Health, 13, 10.1186/1471-2458-13-602 · DOI
  52. Woodard, 2011, Impact of comorbidity type on measures of quality for diabetes care, Med Care, 49, 605, 10.1097/MLR.0b013e31820f0ed0 · DOI
  53. Engel, 2017, Adherence to cardiac practice guidelines in the management of non-st-elevation acute coronary syndromes: a systematic literature review, Curr Cardiol Rev, 13, 3, 10.2174/1573403X12666160504100025 · DOI
  54. Lian, 2014, Diabetes management in the real world and the impact of adherence to guideline recommendations, Curr Med Res Opin, 30, 2233, 10.1185/03007995.2014.952716 · DOI
  55. Wong, 2013, Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status, Diabetes Vasc Dis Res, 10, 505, 10.1177/1479164113496828 · DOI

Cited by

See all 200

Metadata

Authors
Khunti, K., Ceriello, A., Cos, X., & De Block, C.
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2018-03
Volume
137
Pages
137-148
ISSN
0168-8227 (ISSN-L)
OpenAlex
W2784276839
Cited by
200
References
13
FWCI
3.67
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care
  • NIHR Leicester–Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.